Investigations, Enforcement, & Compliance Alerts
Topics
Contributors
Sort by:
1 result
March 10, 2022
|4 min read
FDA Issues Guidance to Clarify Recommendations Regarding Timely Initiation of Voluntary Recalls
Earlier this month, the Food and Drug Administration (“FDA” or “the Agency”) issued guidance to clarify how firms in a product distribution chain, including manufacturers and distributors, should establish voluntary-recall initiation procedures that ensure timely identification and notification of and responses to product problems.